Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152.

Literature DB >> 34581415

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152.

Pragya D Yadav¹, Rima R Sahay¹, Gajanan Sapkal¹, Dimpal Nyayanit¹, Anita M Shete¹, Gururaj Deshpande¹, Deepak Y Patil¹, Nivedita Gupta², Sanjay Kumar³, Priya Abraham¹, Samiran Panda², Balram Bhargava².

Abstract

Entities: Chemical

Keywords: BBV152; Delta; Delta AY.1; SARS-CoV-2; neutralization; variant of concern

Mesh：

Substances：

Year: 2021 PMID： 34581415 PMCID： PMC8500129 DOI： 10.1093/jtm/taab154

Source DB: PubMed Journal: J Travel Med ISSN： 1195-1982 Impact factor: 8.490

× No keyword cloud information.

17 in total

Review 1. Two Years into the COVID-19 Pandemic: Lessons Learned.

Authors: Severino Jefferson Ribeiro da Silva; Jessica Catarine Frutuoso do Nascimento; Renata Pessôa Germano Mendes; Klarissa Miranda Guarines; Caroline Targino Alves da Silva; Poliana Gomes da Silva; Jurandy Júnior Ferraz de Magalhães; Justin R J Vigar; Abelardo Silva-Júnior; Alain Kohl; Keith Pardee; Lindomar Pena
Journal: ACS Infect Dis Date: 2022-08-08 Impact factor: 5.578

Review 2. COVID-19 vaccines: Update of the vaccines in use and under development.

Authors: Rafaela Angotti Marta; Gisele Emy Kondo Nakamura; Bruno de Matos Aquino; Paulo R Bignardi
Journal: Vacunas Date: 2022-06-22

3. Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization.

Authors: Marcilio Jorge Fumagalli; Luiza Antunes Castro-Jorge; Thais Fernanda de Campos Fraga-Silva; Patrick Orestes de Azevedo; Carlos Fabiano Capato; Bruna Amanda Cruz Rattis; Natália Satchiko Hojo-Souza; Vitor Gonçalves Floriano; Julia Teixeira de Castro; Simone Gusmão Ramos; Benedito Antônio Lopes da Fonseca; Vânia Luiza Deperon Bonato; Ricardo Tostes Gazzinelli; Luiz Tadeu Moraes Figueiredo
Journal: Viruses Date: 2021-12-04 Impact factor: 5.048

4. Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy.

Authors: Andreina Baj; Federica Novazzi; Francesca Drago Ferrante; Angelo Genoni; Elena Tettamanzi; Giuseppe Catanoso; Daniela Dalla Gasperina; Francesco Dentali; Daniele Focosi; Fabrizio Maggi
Journal: Emerg Microbes Infect Date: 2021-12 Impact factor: 7.163

10. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.

Authors: Sreelekshmy Mohandas; Pragya D Yadav; Anita Shete; Dimpal Nyayanit; Rajlaxmi Jain; Gajanan Sapkal; Chandrashekhar Mote
Journal: Viruses Date: 2022-03-13 Impact factor: 5.048

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152.

Review 1. Two Years into the COVID-19 Pandemic: Lessons Learned.

Review 2. COVID-19 vaccines: Update of the vaccines in use and under development.

3. Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization.

4. Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy.

5. The outbreak of Delta Plus variant: The notorious and novel strain of SARS-CoV-2.

6. SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera.

Review 7. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy.

Review 8. A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines.

Review 9. Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.

10. Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters.